Some investment analysts are predicting a more permissive M&A market, deregulation as a catalyst for growth and fiscal policies that stimulate economic activity. And they see AI as a catalyst in the shift.
After Luigi Mangione, the man accused of killing UnitedHealthcare CEO Brian Thompson, was extradited to New York, federal prosecutors unsealed a new set of murder charges.
ICU Medical alerted customers to knockoff batteries being circulated by suppliers. Due to a risk of the batteries not holding a charge, the recall has been given the FDA’s most serious designation.
Take a virtual tour around the Radiological Society of North America (RSNA) meeting to see the sights and new technologies displayed across the vast exhibit hall floors.
The U.S. Department of Justice said policies at CVS Health forbade pharmacists from discussing patients and providers who may be prescribing opiates in violation of the Controlled Substance Act.
The Centers for Medicare & Medicaid Services violated the Administrative Procedure Act by allowing a single phone call made by a contractor to determine a Medicare Advantage star rating, a federal judge ruled.
According to a report from the Boston Globe, the search warrants were executed as part of an ongoing criminal investigation into executives at the bankrupt health system.
The FDA’s fledgling Digital Health Advisory Committee (DHAC) only held its first meeting last week, but it has already committed its thinking to writing.
Charles E. Mullins, MD, a U.S. Army veteran who went on to practice medicine for five decades, died at the age of 92. SCAI shared a loving tribute to Mullins, calling him the "father of modern interventional pediatric cardiology."
Some investment analysts are predicting a more permissive M&A market, deregulation as a catalyst for growth and fiscal policies that stimulate economic activity. And they see AI as a catalyst in the shift.
Take a virtual tour around the Radiological Society of North America (RSNA) meeting to see the sights and new technologies displayed across the vast exhibit hall floors.
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
